Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients

Affiliations

• ¹ Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
• ² Bioinformatics and Functional Genomics Group, Cancer Research Center (CiC-IBMCC, CSIC/USAL), Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.
• ³ Molecular Oncology Laboratory, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
• ⁴ Medical Oncology Department, Ramón y Cajal University Hospital, IRYCIS, CIBERONC, Alcalá University, Madrid, Spain.
• ⁵ Facultad de Informática, Universidad Pontificia de Salamanca (UPSA), Salamanca, Spain.
• ⁶ Experimental Therapeutics Unit, Instituto de Investigación Sanitaria San Carlos (IdISSC) and CIBERONC, Madrid, Spain.
• ⁷ Radio-Oncology Department, Ramón y Cajal University Hospital, IRYCIS, Alcalá University, Madrid, Spain.
• ⁸ Medical Oncology Department, Infanta Leonor Hospital, Madrid, Spain.
• ⁹ Medical Oncology Department, Ramón y Cajal University Hospital, IRYCIS, CIBERONC, Alcalá University, Madrid, Spain. cristinapenamaroto@gmail.com.
• ¹⁰ Molecular Oncology Laboratory, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain. vanesa.garciabar@salud.madrid.org.
• ¹¹ Bioinformatics and Functional Genomics Group, Cancer Research Center (CiC-IBMCC, CSIC/USAL), Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain. jrivas@usal.es.